Left atrial appendage morphology and mitral annular plane systolic excursion predict stroke in patients with atrial fibrillation and high thromboembolic risk.

Back

ESC Professional Premium Access

Left atrial appendage morphology and mitral annular plane systolic excursion predict stroke in patients with atrial fibrillation and high thromboembolic risk.

Session: Stroke prediction and prevention in atrial fibrillation

Topic: Stroke in Atrial Fibrillation

Speaker: Doctor D. Blendea (Cluj Napoca, RO)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Dan Blendea

University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)

0 follower

7 more presentations in this session

Atrial fibrillation burden and timing of anticoagulation therapy in patients with screen-detected and clinically-diagnosed AF

Speaker: Doctor W. Sun (Shatin, HK)

Direct oral anticoagulation versus warfarin in atrial fibrillation: a nationwide cohort study of effectiveness and safety among frail patients

Speaker: Mr P. Nielsen (Aalborg, DK)

Validation of novel electrocardiographic classification for stroke prediction in patients with atrial fibrillation undergoing cardioversion

Speaker: Doctor A. Relander (Turku, FI)

Lower dose direct oral anticoagulation and warfarin in atrial fibrillation. Ischemic stroke, intracranial hemorrhage and mortality in a nationwide registry study.

Speaker: Doctor O. Halminen (Espoo, FI)

10-year trends in oral anticoagulation therapies and ischemic stroke among 157,583 patients with non-valvular atrial fibrillation

Speaker: Doctor W. Sun (Shatin, HK)

Access the full session

Stroke prediction and prevention in atrial fibrillation

Speakers: Doctor D. Blendea, Doctor W. Sun, Mr P. Nielsen, Doctor A. Relander, Doctor O. Halminen...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Left atrial appendage morphology and mitral annular plane systolic excursion predict stroke in patients with atrial fibrillation and high thromboembolic risk.

About the speaker

Doctor Dan Blendea

7 more presentations in this session

Atrial fibrillation burden and timing of anticoagulation therapy in patients with screen-detected and clinically-diagnosed AF

Direct oral anticoagulation versus warfarin in atrial fibrillation: a nationwide cohort study of effectiveness and safety among frail patients

Validation of novel electrocardiographic classification for stroke prediction in patients with atrial fibrillation undergoing cardioversion

Lower dose direct oral anticoagulation and warfarin in atrial fibrillation. Ischemic stroke, intracranial hemorrhage and mortality in a nationwide registry study.

10-year trends in oral anticoagulation therapies and ischemic stroke among 157,583 patients with non-valvular atrial fibrillation

Access the full session

Stroke prediction and prevention in atrial fibrillation

About the event

ESC Congress 2023

ESC 365 is supported by